Generic Celebrex is used for treating rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, juvenile arthritis or menstrual pain. It is also used in familial adenomatous polyposis (FAP) to decrease the number of polyps (growths) in the rectal area. More info »
Your email was addressed as a survey and the only link was the one I am responding to now.
To question #1; Did I receive the medication shipment as ordered?
The answer is yes, and I was impressed with the time in which it was delivered to my home; only 10 days!
To question #2; did the medication meet my expectations?
Again the answer is yes! I was also impressed with your website which explains everything about ordering outside the U.S., quality of the medication made at the India labs, number(s) to call if the shipment is held up in Customs, and the ease in placing the order.
- Dave
Nano-Formulated Lower-Dose Oral Diclofenac Provides Acute Pain ReliefMonthly Prescribing Reference“Subjects assessed baseline pain intensity before receiving a single dose of nano-formulated lower dose diclofenac 18mg or 35mg, celecoxib 400mg, or placebo, and pain intensity and pain relief from 15 minutes through 12 hours,” Dr.
Tanezumab has advantages over Celebrex for osteoarthritic pain; report - The Pharma Letter
Tanezumab has advantages over Celebrex for osteoarthritic pain; reportThe Pharma LetterClinical data and the opinions of interviewed thought leaders indicate that Pfizer's investigational compound tanezumab has advantages on this attribute over Pfizer's Celebrex (celecoxib), the sales-leading agent for osteoarthritic pain.
Simulated digestion: Nanomaterial made from lipids and silicon dioxide ... - Nanowerk LLC
Nanowerk LLCSimulated digestion: Nanomaterial made from lipids and silicon dioxide .
Simulated digestion: nanomaterials improve drug absorption - Materials Views (blog)
Materials Views (blog)Simulated digestion: nanomaterials improve drug absorptionMaterials Views (blog)Animal trials with Celecoxib, a drug used to treat arthritis, showed a higher drug content in plasma when the pharmaceutical was orally administered in this new form rather than in its pure state or as drug-containing lipid drops.